{{Rsnum
|rsid=13088089
|Chromosome=3
|position=117061175
|Orientation=plus
|GMAF=0.1804
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 48.2 | 42.0 | 9.8
| HCB | 77.8 | 20.7 | 1.5
| JPT | 71.4 | 25.9 | 2.7
| YRI | 83.6 | 16.4 | 0.0
| ASW | 80.7 | 19.3 | 0.0
| CHB | 77.8 | 20.7 | 1.5
| CHD | 76.6 | 20.6 | 2.8
| GIH | 20.2 | 61.6 | 18.2
| LWK | 88.9 | 11.1 | 0.0
| MEX | 53.4 | 44.8 | 1.7
| MKK | 76.6 | 22.7 | 0.6
| TSI | 40.6 | 46.5 | 12.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=23920401
|Title=Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}